UCP2 and familial pancreatic carcinoma: Combining UCP2 with chemotherapeutic agents as an adjuvant strategy shows potential application value, enhancing effectiveness in inhibiting pancreatic cancer (Dalla et al. 2012; Fiorini et al. 2015).